
LifeMD (LFMD) Stock Forecast & Price Target
LifeMD (LFMD) Analyst Ratings
Bulls say
LifeMD is a promising company with a strong portfolio of brands, partnerships, and revenue growth. Their use of AI and expansion into new areas demonstrate their potential for success, but they may face challenges from competitors and regulatory decisions that could impact their growth. Overall, analysts maintain a positive outlook for this stock, citing potential revenue growth and partnerships as key factors.
Bears say
LifeMD is facing potential enforcement actions from the administration, but believes that the current price point of $149 per month is safe. However, this may change if insurance coverage grows to 80% in 2026, which would result in a lift of about $20 per month. Despite reporting positive financial results, there are risks to consider such as slower growth, difficulty retaining patients, and competition.
This aggregate rating is based on analysts' research of LifeMD and is not a guaranteed prediction by Public.com or investment advice.
LifeMD (LFMD) Analyst Forecast & Price Prediction
Start investing in LifeMD (LFMD)
Order type
Buy in
Order amount
Est. shares
0 shares